title: Renal denervation: a new treatment option in resistant arterial hypertension.
abstract: Hypertension is one of the most prevalent cardiovascular risk factors. Despite this high prevalence and a broad availability of effective pharmaceutical agents, a significant proportion of patients do not reach treatment goals. Partly this can be explained by secondary causes of hypertension or non-compliance of patients. Nevertheless, a subgroup of patients can be diagnosed with 'resistant hypertension'. Activation of the sympathetic nervous system is known to be an important factor in the development and progression of systemic hypertension. In this context, a percutaneous, catheter-based approach has been developed using radiofrequency energy to disrupt renal sympathetic nerves. The first studies have shown this technique to be safe, illustrated by a lack of vascular or renal injury. More importantly, catheter-based renal nerve ablation resulted in a significant reduction in blood pressure on top of traditional medical therapy. Additional to the encouraging effects shown on hypertension, a positive influence of this intervention in other conditions, characterised by sympathetic overactivation, may be expected. Though this technique seems promising, further studies are needed to address long-term safety and efficacy of renal denervation in hypertension and other disease states.
authors.affiliation: Department of Cardiology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands, w.l.verloop@umcutrecht.nl.
authors.forename: W L
authors.initials: WL
authors.lastname: Verloop
authors.forename: M
authors.initials: M
authors.lastname: Voskuil
authors.forename: P A
authors.initials: PA
authors.lastname: Doevendans